Kramer Laboratories

Name

Kramer Laboratories

Legal name

Kramer Laboratories, Inc.

Website

https://kramerlabs.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Over-the-counter consumer healthcare

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Foot Care (Deodorizing, Anti-chafe, Callus Care) (CRADANAK)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• Over-the-counter medicines
• Foot care products
• Cough and cold remedies
• Consumer healthcare brands
• Antifungal treatments

Headquarters

HQ city

Coral Gables

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel

Revenue model

1. Consumer Health Product Sales: Revenue generated from the sale of over-the-counter (OTC) pharmaceutical products, personal care items, and vitamin/mineral supplements distributed under brand names including NIZORAL, NATURELO, FUNGI-NAIL, SAFETUSSIN, KAOPECTATE, and OPTI-NAIL.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Kramer Laboratories markets and distributes a portfolio of branded over-the-counter (OTC) medicines, personal care products, and vitamin/mineral supplements for the foot care and cough-cold segments. Its product lineup includes NIZORAL (antifungal), NATURELO (vitamins/supplements), FUNGI-NAIL (nail fungus), SAFETUSSIN (cough/cold), KAOPECTATE (antidiarrheal), and OPTI-NAIL (nail care), sold through retail and pharmacy channels for consumer self-treatment.

Product overview

Kramer Laboratories, Inc. is a subsidiary of Arcadia Consumer Healthcare, a high-growth consumer health and wellness platform. As a distribution subsidiary, Kramer Laboratories distributes a portfolio of premium, clinically efficacious over-the-counter brands across the OTC, personal care, and vitamin, mineral and supplement categories. The product portfolio includes NIZORAL® (antifungal treatment), NATURELO® (vitamins and supplements), FUNGI-NAIL® (nail fungal treatment), SAFETUSSIN® (cough/cold remedy), KAOPECTATE® (antidiarrheal), and OPTI-NAIL® (nail care). These brands are sold through retail channels and help consumers proactively treat everyday health problems. The company operates as part of a differentiated suite of brands under the Arcadia Consumer Healthcare umbrella, alongside sister subsidiary Atlantis Consumer Healthcare which distributes COLACE®, SENOKOT®, BETADINE®, and SLOWMAG®.

Differentiator

Problem solved

Functional benefit

Brands

• NIZORAL: Over-the-counter healthcare brand distributed by Kramer Laboratories
• NATURELO
• FUNGI-NAIL
• SAFETUSSIN
• KAOPECTATE
• OPTI-NAIL

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Arcadia Consumer HealthcarecoreOthersKramer Laboratories, Inc. is a subsidiary of Arcadia Consumer Healthcare. The company distributes brands including NIZORAL, NATURELO, FUNGI-NAIL, SAFETUSSIN, KAOPECTATE, and OPTI-NAIL under the Arcadia Consumer Healthcare umbrella. Arcadia Consumer Healthcare is described as a high-growth, scaled consumer health and wellness platform with differentiated premium, clinically efficacious brands.

Scale indicators1 record

Recent moves4 records

Broad incumbents

• Church & Dwight: Large diversified consumer products company with meaningful OTC and personal care exposure (e.g., Batiste, Orajel). Comparable in retail distribution and brand stewardship of legacy healthcare/personal care brands, though operates at much larger scale across many categories.
• Haleon: Global consumer healthcare leader (formerly GSK Consumer Healthcare) with major OTC brands across cough/cold, pain relief, and oral health. Directly comparable in OTC category presence and retail pharmacy channel reliance, though operating at multinational scale with vastly larger R&D and marketing budgets.
• Bausch Health Companies: Diversified healthcare company with a meaningful consumer health/OTC portfolio (e.g., antifungal, GI, dermatology brands). Comparable OTC category overlap and pharmacy distribution model, though Bausch operates across prescription pharma as well.
• Bayer Consumer Health: Global OTC and personal care division of Bayer with brands in GI, cough/cold, and dermatology. Comparable in OTC category overlap (e.g., antidiarrheal, antifungal) and pharmacy distribution model, though much larger and more internationally diversified.
• Johnson & Johnson Consumer Health: Major OTC and personal care business behind brands such as Neutrogena, Zyrtec, and Tylenol. Comparable in mass-market OTC distribution and brand-portfolio approach to consumer health, though with vastly deeper R&D resources and global footprint.

Direct peers

• Prestige Consumer Healthcare: US-listed marketer of branded OTC consumer healthcare products across categories including cough/cold, GI, dermatology, and foot care. Closely comparable business model: acquire, revitalize, and distribute established OTC brands through retail and pharmacy channels, often competing head-to-head with Kramer's portfolio.

Emerging players

• GNC Holdings: Specialty retailer and brand marketer of vitamins, minerals, and supplements with overlap to Kramer's NATURELO brand. Comparable in the VMS category and in US retail/pharmacy distribution, though GNC's model is more retail-led.
• Emerson Healthcare: Privately-held US consumer healthcare company marketing OTC and personal care brands through retail channels. Comparable mid-sized brand-marketer model focused on niche OTC/personal care categories, though smaller and earlier-stage than Kramer/Arcadia.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kramer Laboratories